|
Report Date : |
04.07.2012 |
IDENTIFICATION DETAILS
|
Name : |
SUNDER BIOMEDICAL TECH. CO., LTD. |
|
|
|
|
Registered Office : |
|
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
16.07.1998 |
|
|
|
|
Com. Reg. No.: |
16549813 |
|
|
|
|
Legal Form : |
Joint Stock Company |
|
|
|
|
Line of Business : |
Manufacture and trade
of biomedical products and the related products |
|
|
|
|
No. of Employees : |
About 160 Employees. |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2012
|
Country Name |
Previous Rating (31.12.2011) |
Current Rating (31.03.2012) |
|
Taiwan |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Notes:
The exact name and address are as above.
|
Credit Opinion: |
Subject was incorporated on
The information above is that of subject’s major shareholders.
Factory:
|
Address |
No. 16, Chung-Chen Rd., Chung-Ming Village,
Pao-Chung Hsiang, Yunlin County 634, Taiwan R. O. C. |
|
Telephone Number |
+886-5-697 6985 |
|
Fax Number |
+886-5-697 6986 |
PVC Compound Factory
Office:
|
Address |
No.57, Da-Lun Street., Da-Lun Village, Fu-Xing
Siang, Changhua County 50641, Taiwan R. O. C. |
Related Company
|
Name: |
Sunder Medical Pte. Ltd. |
|
Address |
7 Kallang Place, #06-10, Singapore 339153 |
|
Telephone Number |
+65-6396 3363 |
|
Fax Number |
+65-6396 3392 |
Core
Management
|
1 |
|
|
Name |
Zhikai Hu |
|
Position |
Board of Chairman |
|
2 |
|
|
Name |
Rujian Lai |
|
Position |
Director |
|
3 |
|
|
Name |
Mega International
Commercial Bank Co., Ltd. |
|
Position |
Director |
|
4 |
|
|
Name |
Junzhou Chen |
|
Position |
Director |
|
5 |
|
|
Name |
Jiefu Investment Co.,
Ltd(translated) |
|
Position |
Director |
|
6 |
|
|
Name |
Jisheng Co.,
Ltd(translated) |
|
Position |
Director |
|
7 |
|
|
Name |
Deyang Biomedical Tech.
Co., Ltd. |
|
Position |
Supervisor |
|
8 |
|
|
Name |
Mengzong Xie |
|
Position |
Supervisor |
Personnel
Structure
|
Total Employees |
About 160 Employees. |
Offices
& Factories
|
|
Headquarters |
|
Add |
|
Production
Information
l
Subject is a manufacturer of biomedical products and the related products
with the production activities
Purchase
Information
l
The registered activities of subject:
|
Business Code |
Details |
|
C802041 |
Manufacture of
western medicine |
|
F108021 |
Wholesale of
western medicine |
|
CF01011 |
Manufacture of
medical equipment |
|
F108031 |
Wholesale of
medical equipment |
|
F401010 |
International
trade |
|
ZZ99999 |
Besides licensed
business, all other business items those are not banned or restricted. |
l
The components and raw material for production are
mostly purchased from abroad.
Sales
Information
l
Subject is mainly engaged in manufacturing and
trading of biomedical products and the
related products.
l
Subject introduced that its major products sold
|
|
Product |
|
1 |
Blood Line Set
for Hemodialysis |
|
2 |
Surgical Tubing
Set |
|
3 |
Priming Tube |
|
4 |
Blood Line Set
for Components |
|
5 |
Transducer
Protector |
|
6 |
A.V. Fistula
Needle Set |
|
7 |
PVC compounds
for medical applications |
|
8 |
Intranasal
Splint |
|
9 |
Others |
l
Subject’s selling territory covers all over the
world.
Import and export
right:
|
Import right |
Yes |
|
Export right |
Yes |
Purchase
Subject declined to disclose the purchase settlements information, and
from other sources, we couldn’t obtain the information, either.
Sales
Domestic Markets
|
Sales Terms |
Proportion |
|
|
Biomedical products
and the related products. |
COB, CBD, etc |
100% |
Export
|
Sales Terms |
Proportion |
|
|
Biomedical
products and the related products. |
L/C , T.T, etc. |
100% |
Notes:
Subject’s settlement for export is generally in USD
Subject has no obligations to disclose its financial statements to the third party according to the relevant policy in Taiwan and the only source from which we can obtain the information is the subject itself.
Subject’s relevant staff Ms. Shen declined to disclose its financials citing the grounds of company’s confidentiality; from other source we can not obtain the relevant information, either.
The bankers’
information is not available from the subject or other sources.
Mortgage
No chattel mortgage record of subject has been found within the recent 3
months.
Lawsuit
Up to date of
reporting, no existing or latent litigation of the subject has been found.
|
Name |
Ms. Shen |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.54.81 |
|
UK Pound |
1 |
Rs.86.04 |
|
Euro |
1 |
Rs.69.62 |
INFORMATION DETAILS
|
Report Prepared
by : |
MNL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.